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ttp://dx.doi.org/10.1016/j.ajpath.2013.04.005Severe acute kidney injury (AKI) is frequently accompanied by maladaptive repair and renal ﬁbro-
genesis; however, the molecular mechanisms that mediate these acute and chronic consequences of
AKI remain poorly understood. In this study, we examined the role of epidermal growth factor
receptor (EGFR) in these processes using waved-2 (Wa-2) mice, which have reduced EGFR activity, and
their wild-type (WT) littermates after renal ischemia. Renal EGFR phosphorylation was induced within
2 days after ischemia, increased over time, and remained elevated at 28 days in WT mice, but this was
diminished in Wa-2 mice. At the early stage of postischemia (2 days), Wa-2 mice developed more
severe acute renal tubular damage with less reparative responses as indicated by enhanced tubular
cell apoptosis, and reduced dedifferentiation and proliferation as compared to WT animals. At the late
stage of postischemia (28 days), Wa-2 mice exhibited a less severe renal interstitial ﬁbrosis as shown
by reduced activation/proliferation of renal myoﬁbroblasts and decreased deposition of extracellular
matrix proteins. EGFR activation also contributed to cell cycle arrest at the G2/M phase, a cellular
event associated with production of proﬁbrogenetic factors, in the injured kidney. Collectively, these
results indicate that severe AKI results in sustained activation of EGFR, which is required for
reparative response of renal tubular cells initially, but eventually leads to ﬁbrogenesis. (Am J Pathol
2013, 183: 160e172; http://dx.doi.org/10.1016/j.ajpath.2013.04.005)Supported by NIH grant DK-085065 (S.Z.), National Nature Science
Foundation of China grants 81270778 (S.Z.), 81170638 (H.Y.), and
81200492 (N.L.), and the Pudong New District Foundation of China
(PWZxk2010-02).Acute kidney injury (AKI) is a serious clinical problem with
mortality approaching 50%. After injury, the kidney can
either be completely repaired, leaving no lasting evidence of
damage, or incompletely repaired, resulting in renal ﬁbrosis.
Currently, approximately one-third of patients with AKI
progress to chronic kidney disease (CKD), which is charac-
terized by tubular atrophy, proliferation of renal interstitial
myoﬁbroblasts, persistent tubulointerstitial inﬂammation,
and excessive deposition of extracellular matrix proteins.1,2
As AKI is a major cause of CKD and AKI can also exacer-
bate CKD and hasten development of end-stage renal dis-
ease,3e5 understanding the molecular events that determine
physiological repair and pathological ﬁbrosis of the kidney
may lead to therapeutic interventions that promote renal
repair and prevent development of renal ﬁbrosis.
Emerging evidence suggests that tyrosine kinase receptors
play important roles in renal epithelial repair and regen-
eration. It has been reported that speciﬁc epidermal growthstigative Pathology.
.factor receptor (EGFR) deletion in the renal proximal tubule
or treatmentwith erlotinib, a speciﬁc EGFR inhibitor, delayed
renal function recovery following ischemia/reperfusion (I/R)
injury.6 Similarly, Waved-2 (Wa-2) mice expressing a point
mutation in EGFR that reduces receptor tyrosine kinase
activity by 90% resulted in a slow recovery of renal function
after AKI.7 On the other hand, activation of EGFR with
exogenous EGF or heparin-binding EGF-like growth factor
(HB-EGF) can accelerate tubular cell proliferation and
promote renal functional recovery after acute ischemic
injury.8,9 These studies suggest that EGFR activation is
involved in the regulation of renal repair and functional
recovery after AKI.
EGFR Mediates Renal Repair and FibrosisHowever, several studies have also indicated that EGFR
activation contributes to the development and progression of
renal ﬁbrosis after chronic kidney injury. For example,
transgenic mice overexpressing a kidney tubule-speciﬁc,
dominant-negative EGFR construct attenuated tubulointer-
stitial ﬁbrotic lesions in the kidney after subtotal renal
ablation or following chronic infusion of angiotension II
(Ang II).10,11 Pharmacological inhibition of EGFR with
geﬁtinib prevented the decline of renal function and reduced
the development of renal vascular and glomerular ﬁbrosis in
a rat model of NG-nitro-L-arginine methyl ester (L-NAME)-
induced hypertension.12 Moreover, genetic and pharmaco-
logical blockage of EGFR attenuated renal ﬁbrosis induced
by unilateral ureteral obstruction (UUO) injury.13
EGFR is a transmembrane receptor with intrinsic tyrosine
kinase activity and is expressed in both renal epithelial cells
and renal interstitial ﬁbroblasts.14e16 Ligand binding to
EGFR induces it to phosphorylate speciﬁc tyrosine residues
within its cytoplasmic domains, which serve as docking
sites for signaling molecules, and subsequently initiating
activation of multiple intracellular signaling pathways, such
as the extracellular signal-regulated kinase1/2 (ERK1/2)
pathway, the phosphoinositide-3-kinase (PI3K)/Akt path-
ways and the Janus kinase/signal transducers and activators
of transcription (JAK/STAT) pathways. Activation of these
pathways triggers expression of numerous genes needed for
several biological cellular responses, including cell survival,
proliferation, dedifferentiation, and ﬁbrosis.17e19
Although EGFR has been shown to mediate both tubular
reparative and ﬁbrotic responses after injury, all those ob-
servations were made separately in different acute or chronic
kidney injury models. To date, a fundamental unanswered
question is whether EGFR is activated in both the early and
late phases of injury and mediates both repair and ﬁbrotic
responses in the same animal models. In addition, it is also
unclear whether EGFR exerts these functional effects by
acting in different cell types. In this study, we attempted to
address these issues by using a mouse model of severe AKI
induced by unilateral I/R injury. Our data indicated that
severe I/R injury induces a sustained EGFR activation, which
is essential for the tubular cell regenerative response at the
early stage of reperfusion, but eventually leads to the acti-
vation/proliferation of renal interstitial myoﬁbroblasts and
development of renal ﬁbrosis in this model.
Materials and Methods
Antibodies and Reagents
Antibodies against p-EGFR, p-STAT3, STAT3, p-Akt, Akt,
and vimentin were purchased from Cell Signaling Tech-
nology (Dancers, MA). Antibody to Pax-2 was purchased
from Invitrogen (Carlsbad, CA). Antibodies to EGFR,
proliferating cell nuclear antigen (PCNA), GAPDH,
collagen 1(A2), and ﬁbronectin were purchased from Santa
Cruz Biotechnology (Santa Cruz, CA). Antibody againstThe American Journal of Pathology - ajp.amjpathol.orgp-histone H3 was purchased from Abcam (Cambridge,
MA). Antibody to neutrophil gelatinase-associated lipocalin
(NGAL) was purchased from R&D Systems (Minneapolis,
MN). Antibody to a-smooth muscle actin (a-SMA) and
a-tubulin, all secondary antibodies, and all other chemicals
were from Sigma-Aldrich (St. Louis, MO).
Wa-2 Mice and Unilateral I/R Model
Wa-2 mice were maintained on a C57BL/6JeiC3H/HeSnJ
background (Jackson Laboratory, Bar Harbor, ME).20 The
unilateral I/R model was established in 6- to 8-week-old male
Wa-2 mice and their wild-type (WT) littermates, with six
mice in each group. Mice were anesthetized with 75 mg/kg
ketamine (i.p.) and 50 mg/kg dexmedetomidine (Dexdomi-
tor) (i.m.). A ﬂank incision was made on the left side; the
renal arteries and veins were isolated from the surrounding
tissue by blunt dissection and then occluded with a non-
traumatic vascular clamp (85-g pressure; Roboz Surgical
Instruments, Gaithersburg, MD) for 45 minutes at 37C. The
sham-operated kidney was used as the control, in which the
renal pedicles were isolated, but no clamps were applied. At
days 2, 7, 14, or 28 after surgery, animals were sacriﬁced and
the kidneys were collected and then horizontally cut into two
pieces. One piece of the kidney was ﬁxed in formaldehyde
and used for immunoﬂuorescence, immunochemistry, and
Masson’s trichrome staining; another piece was snap-frozen
in liquid nitrogen and used for immunoblot analysis. Because
the healthy contralateral kidney can complement the function
of the injured kidney, there is usually no azotemia in this
model. Thus, renal function was not measured.
Tubular Injury
Tubular injury was scored on a scale from 0 to 3, where 0Z
normal, 1 Z injury <30%, 2 Z injury 30% to 60%, 3 Z
injury >60%. To detect cell death, kidneys were removed at
day 2 after I/R injury. The TUNEL staining was performed
according to the protocol provided by Roche Molecular
System (Branchburg, NJ).
Immunoblot Analysis
Immunoblot analysis for tissue samples was performed
according to our previous protocols.21 The densitometry
analysis of immunoblot results was conducted with ImageJ
software version 1.45 (NIH, Bethesda, MD).
Immunohistochemical and Immunoﬂuorescent
Staining
Immunoﬂuorescence staining was performed according to
the procedure described in our previous studies.21 Renal
tissues were ﬁxed in 4.5% buffered formalin, dehydrated,
and then embedded in parafﬁn. For immunoﬂuorescent
staining, the tissue sections were rehydrated and labeled161
Tang et alwith antibodies, including primary antibodies Pax-2 (1:50),
PCNA (1:50), p-EGFR (1:50), a-SMA (1:200), p-histone
H3 (1:250), p-STAT3 (1:100), and p-Akt (1:100), and then
exposed to ﬂuorescein isothiocyanate or Texas RedelabeledFigure 1 EGFR activation in the kidney of WT and Wa-2 mice following
I/R injury. Unilateral I/R injury was performed in the left kidney of both WT
and Wa-2 mice. At days 2, 7, 14, or 28 (AeC) or 2 days (DeG), the kidney
was removed for immunoblot analysis of p-EGFR, EGFR, and GAPDH or
a-tubulin (AeF). The expression levels of p-EGFR, EGFR, GAPDH, or
a-tubulin were calculated by densitometry, and the ratio between p-EGFR
and total EGFR was determined (B and E). Total EGFR levels were normalized
with GAPDH or a-tubulin (C and F). The kidney tissues collected at day 2
were used for staining with antibody against p-EGFR in the sham and the
I/R injury groups. G: The tubular cells were stained with p-EGFR. All data
are represented as means  SEM (nZ 6). Representative immunoblots are
from two or three samples from six animals in each group. Means with
different symbols are signiﬁcantly different from one another. P < 0.05.
162secondary antibodies (Invitrogen). PAS staining was per-
formed in the Department of Pathology at Rhode Island
Hospital. Masson’s trichrome staining was performed
according to the procedure described by the manufacturer
(Sigma-Aldrich). For quantitative assessment of renal
ﬁbrosis, the collagen tissue area (blue color) was measured
using Image Pro-Plus software version 7 (Media-Cyber-
netics, Silver Spring, MD) by drawing a line around the
perimeter of positive staining area, and the average ratio to
each microscopic ﬁeld (100) was calculated and graphed.
Statistical Analysis
All data were presented as means  SEM for each group.
Comparisons between intergroups were made using one-
way analysis of variance followed by Tukey’s test. Statis-
tically signiﬁcant differences were considered at P < 0.05.
Results
Phosphorylation and Expression of EGFR in the Kidney
after I/R Injury in WT and Wa-2 Mice
As an initial step toward understanding the role of EGFR in
renal repair and renal ﬁbrosis, we examined the phosphory-
lation and expression of EGFR in the kidney after I/R injury
in Wa-2 mice and their WT littermates. To induce the severe
kidney injury that is able to trigger ﬁbrogenesis and to ensure
enough survival animals (at least six) for analysis, a model of
unilateral renal ischemia for 45 minutes was used. As shown
in Figure 1, AeC, I/R injury induced phosphorylation of
EGFR in the kidneys of WT mice, which was slightly
increased at day 2, remained at similar levels at day 7, peaked
at day 14, and remained elevated at 28 days. Total EGFR was
also increased at day 2 and then gradually increased until 28
days after ischemia. However, the up-regulation of phos-
phorylated EGFR (p-EGFR) was not only due to the
increased level of total EGFR because the ratio of p-EGFR to
total EGFR was still increased in a time-dependent manner
during the course of I/R injury (Figure 1B). In Wa-2 mice,
renal p-EGFR levels were signiﬁcantly inhibited at both the
early (day 2) (Figure 1, D and E) and the late phase (day 28)
of the injury (Supplemental Figure S1). The renal EGFR
level in Wa-2 mice was not altered at day 2 (Figure 1, D and
F), but was slightly reduced at day 28 after ischemic injury
(Supplemental Figure S1). Immunoﬂuorescent staining
showed that p-EGFR was primarily located in renal tubular
cells in the early phase (day 2) of I/R injury (Figure 1G), but it
was also observed in interstitial myoﬁbroblasts as indicated
by co-localization of a-SMA and p-EGFR (Supplemental
Figure S2C). Further, myoﬁbroblasts are mostly localized
in the area with severely damaged renal tubules, but rare to
ﬁnd in areas with less tubular damage (Supplemental
Figure S2, AeC) at 2 days after I/R injury. The number of
cells expressing both a-SMA and p-EGFR or a-SMA or
p-EGFR alone were markedly reduced in the kidneys ofajp.amjpathol.org - The American Journal of Pathology
Figure 2 Indices of injury in WT and Wa-2 mice
after I/R-induced AKI. A: Photomicrographs
(200) illustrate PAS staining of the kidney
tissues in WT and Wa-2 mice. B: Morphological
changes were scored based on the scale described
in Materials and Methods. C: Photomicrographs
(400) illustrate TUNEL staining of the kidney
tissues in WT and Wa-2 mice at day 2 after I/R
injury. D: Positive TUNEL staining cells were
counted in 10 high-power ﬁelds and expressed as
means  SEM. E: Kidney tissue lysates were sub-
jected to immunoblot analysis with speciﬁc anti-
bodies against NGAL and GAPDH. F: The expression
level of NGAL was quantiﬁed by densitometry and
normalized with GAPDH. Data are means  SEM
(n Z 6). Representative immunoblots are from
two samples from six animals in each group. Means
with different symbols are signiﬁcantly different
from one another. P < 0.05.
EGFR Mediates Renal Repair and FibrosisWa-2 mice (Supplemental Figure S2D). These data illus-
trated that the kidney exposed to severe ischemic injury led to
EGFR activation, which occurs predominately in tubular
cells and also in myoﬁbroblasts in the early phase of AKI.
Further, EGFR activation is required for activation of renal
interstitial ﬁbroblasts.Reduction of EGFR Kinase Activity Potentiates the
Kidney Damage in the Early Phase of I/R-Induced AKI
To determine the role of EGFR activation in I/R-induced AKI,
changes in kidney morphology, apoptosis, and expression of
the injury marker neutrophil gelatinase associated lipocalin
(NGAL),22 were assessed at 2 days after ischemia. Tubular
dilation, swelling, necrosis, luminal congestion, and hemor-
rhage were present in the kidneys ofWTmice subjected to I/R
injury, but these changes were more severe in Wa-2 mice
(Figure 2A). Scoring of kidney sections for histopathological
damage to the tubules showed an increase in renal damage in
Wa-2 mice as compared with WT mice (Figure 2B). Sham-
operated WT and Wa-2 mice incurred no tubular injury
(Figure 2, A and B). The TUNEL staining showed more
positivity in renal tubular cells of Wa-2 mice compared withThe American Journal of Pathology - ajp.amjpathol.orgWTmice after I/R injury (Figure 2, C and D). NGAL was not
detected in control kidneys by immunoblot analysis, but its
expression level was increased in the kidney of WT mice after
I/R injury and further increased in the injured kidneys ofWa-2
mice (Figure 2, E and F). Immunoﬂuorescent staining showed
that NGAL expression is limited to renal proximal tubular cells
(data not shown). Taken together, these data indicate that
EGFR activation is necessary for renoprotection in the early
phase of AKI.EGFR Activation Is Required for Renal Tubular Cell
Dedifferentiation and Proliferation in the Early Phase
of I/R-Induced AKI
Fate mapping studies indicated that renal repair after AKI
is carried out mainly by proliferation of dedifferentiated
intrinsic renal tubular cells.23 Although EGFR has been
shown to be involved in renal tubular cell proliferation
after AKI,7 little is currently known about the signaling
mechanism that regulates renal tubular cell dedifferentia-
tion in response to injury in vivo. Our previous studies
showed that EGFR activation plays a regulatory role in
primary cultures of renal tubular cell dedifferentiation after163
Figure 3 Expression of Pax-2, vimentin, and
PCNA in WT and Wa-2 mice after I/R-induced AKI.
A: Photomicrographs (200) illustrate Pax-2 with
immunoﬂuorescent staining of the kidney tissues
collected at day 2 after sham and I/R injury in WT
and Wa-2 mice. B: Tubular cells with positive
staining of Pax-2 were counted in 10 high-power
ﬁelds and expressed as means  SEM. C: The
kidney tissue lysates were subjected to immunoblot
analysis with speciﬁc antibodies against vimentin
and GAPDH. D: The expression level of vimentin
was quantiﬁed by densitometry and normalized
with GAPDH. Data are means  SEM (n Z 6). E:
Photomicrographs (200) illustrate PCNA with
immunoﬂuorescent staining of the kidney tissues
collected at day 2 after sham and I/R injury in WT
and Wa-2 mice. F: The tubular cells with positive
staining of PCNA were calculated in 10 high-power
ﬁelds and expressed as means  SEM. G: The
kidney tissue lysates were subjected to immunoblot
analysis with speciﬁc antibodies against PCNA and
a-tubulin. H: The expression level of PCNA was
quantiﬁed by densitometry and normalized with a-
tubulin. Data are means  SEM (n Z 6). Repre-
sentative immunoblots are from three samples from
six animals in each group. Means with different
symbols are signiﬁcantly different from one
another. P < 0.05.
Tang et aloxidant injury.24 Here, we further examined whether
EGFR also mediates this process in injured kidney at 2
days after ischemia. As shown in Figure 3, A and B, Pax2,
a hallmark of dedifferentiation of renal epithelial cells
located in nuclei,25 is absent in healthy adult tubules, but
was re-expressed in the kidneys of WT mice after I/R
injury. Its expression was markedly decreased in the
kidneys of Wa-2 mice. Similarly, vimentin, another marker
of renal tubular cell dedifferentiation, was also re-
expressed in the kidneys of WT mice subjected to I/R
injury and signiﬁcantly decreased in Wa-2 mice (Figure 3,
C and D).
Dedifferentiated renal tubular cells acquire the ability to
proliferate and migrate, and proliferation of intrinsic renal
epithelial cells has been recognized as the predominant
mechanism of renal regeneration.26 We further examined164the role of EGFR in renal tubular proliferation in the
injured kidney by assessing expression of PCNA,
a marker of cell proliferation, at 2 days after ischemia.
Immunoﬂuorescence staining showed that PCNA was
mainly expressed in the nucleus of proximal tubular cells,
and the number of PCNA-positive cells was increased in
the injured kidneys of WT mice but signiﬁcantly
decreased in Wa-2 mice (Figure 3, E and F). A very small
number of PCNA-positive cells was also observed in the
kidneys of WT control mice, reﬂecting the minimal turn-
over rate of renal tubular cells under physiological
conditions. Western blot analysis conﬁrmed such changes
in the kidneys of WT and Wa-2 mice after I/R injury
(Figure 3, G and H). Therefore, these results indicated that
EGFR activation is required for renal tubular cell dedif-
ferentiation and proliferation following I/R injury.ajp.amjpathol.org - The American Journal of Pathology
Figure 4 Expression of STAT3 and Akt in WT and Wa-2 mice after I/R-
induced AKI. A: The kidney tissue lysates were subjected to immunoblot anal-
ysis with speciﬁc antibodies against p-STAT3, STAT3, p-Akt, Akt, and a-tubulin.
The expression levels of p-STAT3, STAT3, p-Akt, and Akt were quantiﬁed by
densitometry, and the ratios between phosphorylated and total proteins were
calculated (B and D). Total STAT3 (C) and Akt (E) were normalized with a-
tubulin. Data are means SEM (nZ 6). Representative immunoblots are from
three samples from six animals in each group. Means with different symbols are
signiﬁcantly different from one another. P < 0.05.
EGFR Mediates Renal Repair and FibrosisEGFR Activation Is Required for STAT3 and Akt
Phosphorylation in the Early Phase of I/R-Induced AKI
Because activation of STAT3 and Akt signaling pathways
has been reported to be associated with cell survival and
proliferation,27e30 we examined the phosphorylation status
of renal STAT3 and Akt in WT and Wa-2 mice in the early
time course of I/R-induced AKI. Phospho-Akt (p-Akt) and
phospho-STAT3 (p-STAT3) were not detectable in sham-
operated kidneys, and their levels were increased in the
kidney of WT mice subjected to I/R injury. However, I/R-
induced expression of p-Akt and p-STAT3 was signiﬁ-
cantly suppressed in the kidneys of Wa-2 mice (Figure 4, A,
B, and D). Total STAT3 and Akt were also increased in the
injured kidneys of WT mice, but remained at the same levels
in the kidneys of Wa-2 mice (Figure 4, A, C, and E). These
data suggest that EGFR may regulate renal regenerative
responses through activation of, at least, the STAT3 and Akt
signaling pathways.
EGFR Activation Contributes to Renal Fibrogenesis at
the Late Phase of I/R Injury
AKI can progress to CKD,3e5 which is characterized by
activation of renal interstitial ﬁbroblasts (as indicated by
expression of a-SMA) and expression of extracellular
matrix proteins (ie, ﬁbronectin and collagen I).31e33 We
investigated whether EGFR activation is associated with
renal ﬁbrogenesis after AKI. As shown in Figure 5, AeD,
basal levels of collagen I and a-SMA were detected in the
kidneys of WT mice. After I/R injury, their expression
levels were slightly elevated at 2 days, further increased at 7
days, and reached the maximum at 14 and 28 days
(Figure 5, AeC). Fibronectin was not detectable in control
kidneys. After I/R injury, its expression was induced at 14
days and continuously elevated up to 28 days after I/R
injury in the kidney of WT mice (Figure 5, A and D). By
contrast, the expression level of ﬁbronectin was signiﬁcantly
reduced, and collagen I and a-SMA were suppressed to
basal levels at 28 days in Wa-2 mice subjected to chronic I/
R injury (Figure 5, EeH). Consistent with those observa-
tions, I/R injury also induced expression of interstitial
collagen ﬁbrils in the kidney of WT mice at 14 and 28 days,
which was reduced in Wa-2 mice as demonstrated by
Masson’s trichrome staining (Figure 6, A and B, and
Supplemental Figure S3).
Transformation of interstitial ﬁbroblasts into a-SMAe
positive myoﬁbroblasts is the main mechanism for
production of extracellular matrix proteins in the evolution
of CKD.32,34 We therefore examined localization and
expression of a-SMA and p-EGFR in the kidneys of both
WT and Wa-2 mice at 28 days after I/R injury. p-EGFR
was colocalized with most of the a-SMA-positive cells
(Figure 6, C and D) and also expressed in the renal tubular
cells of the injured kidney (Supplemental Figure S1),
indicating that p-EGFR is expressed in both renalThe American Journal of Pathology - ajp.amjpathol.orginterstitial myoﬁbroblasts and tubular epithelial cells in the
late phase of ischemic injury. Taken together with dimin-
ished expression of a-SMA, collagen I, and ﬁbronectin in
the injured kidneys of Wa-2 mice, this suggests that EGFR
plays a critical role in mediating activation of renal inter-
stitial myoﬁbroblasts and renal ﬁbrogenesis after pro-
longed I/R injury.
EGFR Activation Is Required for Expression of PCNA in
Renal Myoﬁbroblasts after I/R Injury
Another feature of renal ﬁbrogenesis is proliferation of renal
interstitial myoﬁbroblasts. Because EGFR activation has
been demonstrated to be associated with proliferation of
cultured renal ﬁbroblasts in vitro,13 we here examined
whether EGFR activation also contributes to their prolifer-
ation in vivo after I/R injury by measuring expression of
PCNA. Western blot analysis indicated that PCNA was
barely detectable in the kidney of the sham-operated WT
mice; I/R injury induced its expression, and none was
detected in Wa-2 mice (Figure 7, A and B). Consistent with
this observation, immunostaining showed a large number of
PCNA-positive cells in the kidneys of WT mice after I/R165
Figure 5 Time course and expression level of
collagen I, ﬁbronectin, and a-SMA after I/R injury
in WT and Wa-2 mice. A: The kidneys were
collected at days 2, 7, 14, or 28 for analyzing the
expression of collagen I, a-SMA, ﬁbronectin, and
a-tubulin. The expression levels of collagen I (B),
a-SMA (C), and ﬁbronectin (D) were quantiﬁed by
densitometry and normalized with a-tubulin. E:
Kidney tissue lysates were subjected to immuno-
blot analysis with speciﬁc antibodies against
ﬁbronectin, a-SMA, and collagen I at day 28 after
I/R injury in WT and Wa-2 mice. The expression
levels of ﬁbronectin (F), a-SMA (G), and collagen I
(H) were quantiﬁed by densitometry and normal-
ized with a-tubulin. Data are means  SEM (n Z
6). Representative immunoblots are from two
samples from six animals in each group. Means
with different symbols are signiﬁcantly different
from one another. P < 0.05.
Tang et alinjury, and a smaller number of PCNA-positive cells was in
the kidney of Wa-2 mice. In the early phase of AKI, we
observed that PCNA is mostly expressed in the nucleus of
tubular cells (Figure 3E). In contrast to this, PCNA was
mainly expressed in the cytoplasm of interstitial renal
myoﬁbroblasts 28 days after I/R injury, which is indicated
by its colocalization with a-SMA (Figure 7, C and D). To
conﬁrm the localization of PCNA in renal interstitial myo-
ﬁbroblasts, cultured NRK-49F cells were also stained with
antibodies against PCNA, a-SMA, and DAPI. As shown in
Supplemental Figure S4, PCNA is localized in the cyto-
plasm of NRK-49F cells. Because it has been reported that
PCNA expressed in the cytoplasm of neutrophils promotes
cell survival,35,36 the same location of PCNA in renal
interstitial ﬁbroblasts may also play a protective role in
addition to its growth promoting effects (see Discussion).
EGFR Activity Contributes to Renal Epithelial Cell Arrest
in the G2/M Phase of Cell Cycle after I/R Injury
It has been shown that renal tubular cells arrested in the
G2/M phase demonstrate a prominent proﬁbrotic phenotype
and result in increased production of proﬁbrotic growth
factors/cytokines.37 Phosphorylation of histone H3 (p-H3)
at serine 10 is a hallmark of cells in G2/M phase.38 To166understand the role of EGFR in this process, we examined
the expression of p-H3 by immunoblot analysis and im-
munostaining in WT and Wa-2 mice subjected to I/R injury.
As shown in Figure 8, A and B, a large number of renal
tubular cells labeled with p-H3 were detected in WT mice at
28 days after I/R injury; the number of p-H3epositive cells
was signiﬁcantly decreased in the injured kidney of Wa-2
mice. Consistent with this observation, immunoblot anal-
ysis showed that p-H3 was barely observed in sham-
operated mice, but its expression was increased in the
kidney of WT mice after I/R injury and decreased in Wa-2
mice (Figure 8, C and D). Thus, activation of EGFR is
essential for driving renal epithelial cell cycle to arrest at
G2/M phase after I/R injury.
EGFR Mediates the Phosphorylation of STAT3 and Akt
after Prolonged I/R Injury
STAT3 has been shown to be activated in the obstructed
kidney and is associated with the development and
progression of renal ﬁbrosis in a murine model of UUO.21,34
The Akt pathway was also shown to mediate HB-
EGFeinduced heart ﬁbrosis and proliferation of cardiac
ﬁbroblasts.39 Thus, we examined whether EGFR also
mediates the activation of these signaling pathways at theajp.amjpathol.org - The American Journal of Pathology
Figure 6 Genetic inhibition of EGFR reduces
renal ﬁbrosis in I/R-induced chronic kidney injury.
A: Photomicrographs (100) illustrate Masson
trichrome staining of the kidney tissue at 28 days
after I/R injury in WT and Wa-2 mice. B: Masson’s
trichromeepositive tubulointerstitial area (blue)
relative to the whole area from 10 random cortical
ﬁelds was analyzed and expressed as means 
SEM. C: Photomicrographs (200) illustrate cos-
taining of p-EGFR and a-SMA in kidney tissues
collected at day 28 after sham and I/R injury in WT
and Wa-2 mice. D: Positive staining of a-SMA or
p-EGFR or both of them together in WT and Wa-2
mice after I/R injury were counted in 10 high-
power ﬁelds and expressed as means  SEM.
Means with different symbols are signiﬁcantly
different from one another. P < 0.05.
EGFR Mediates Renal Repair and Fibrosislater stage of I/R injury. As shown in Figures 9 and 10,
phosphorylated levels of STAT3 and Akt were signiﬁcantly
increased at 28 days after I/R injury in WT mice. By
contrast, phosphorylated STAT3 and Akt levels were
diminished in the injured kidney of Wa-2 mice. Immuno-
ﬂuorescent co-staining of p-STAT3 and a-SMA indicated
that p-STAT3 was mainly expressed in renal interstitial
myoﬁbroblasts (Figure 9D), which was consistent with its
localization in UUO-injured kidneys.34 Further, co-staining
of p-Akt with a-SMA was also observed in the injured
kidneys of WT mice (Figure 10D). Expression levels of
both were markedly reduced in the kidneys of Wa-2 mice
(Figures 9 and 10). These data, combined with localization
of p-EGFR in renal myoﬁbroblasts at the later stage of AKI,
suggest that EGFR may mediate activation and proliferation
of renal myoﬁbroblasts through activation of STAT3 and
Akt signaling pathways.
Discussion
AKI can lead to complete or incomplete tubular repair,
depending on the severity of the insult. After mild injury,
renal repair usually results in a return to a normal structural
and functional state, but severe injury is frequently
accompanied by the development of renal ﬁbrosis.40,41 TheThe American Journal of Pathology - ajp.amjpathol.orgmolecular mechanism that determines renal tubular repair
and the ﬁbrotic responses to injury remains poorly under-
stood. Here, we took an advantage of a murine model of
unilateral severe I/R-induced AKI to determine whether
EGFR plays a pivotal role in these processes. Our results
indicate that severe I/R injury induced a sustained activa-
tion of EGFR, which is required for renal regenerative
responses (tubular cell dedifferentiation and proliferation)
in the early phase, but is in turn, a critical mediator of renal
ﬁbrogenesis in the later phase of AKI. Thus, we suggest
that EGFR exerts dual roles in the course of severe AKI
and that sustained EGFR activation is a critical molecular
event that leads to development of renal tubulointerstitial
ﬁbrosis.
Ischemic injury is a common cause of AKI. Following
injury, some tubular epithelial cells die by apoptosis and
necrosis. The surviving tubular cells undergo dedifferenti-
ation, proliferation, and migration, ﬁnally re-differentiating
into mature tubular epithelial cells.42 Dedifferentiation
of renal epithelial cells is the initial step of the renal
regenerative response after injury. Although our in vitro
studies have shown that EGFR activation regulates dedif-
ferentiation of renal tubular cells in primary cultures of
renal tubular cells after oxidant injury,24 the regulatory
mechanism in vivo remains unclear. In this study, we167
Figure 7 Expression and location of PCNA after
chronic I/R injury in WT and Wa-2 mice. A: The
kidney tissue lysates were subjected to immuno-
blot analysis with speciﬁc antibodies against PCNA
and a-tubulin. B: The expression levels of PCNA
and a-tubulin were quantiﬁed by densitometry and
normalized with a-tubulin. Data are means  SEM
(n Z 6). Representative immunoblots are from
two samples from six animals in each group. C: The
kidney tissues collected at day 28 were used for
co-staining with antibodies to PCNA and a-SMA,
and overlay with DAPI. D: Positive staining (400)
of both PCNA and a-SMA, or a-SMA, or PCNA alone
were counted in 10 high-power ﬁelds and
expressed as means  SEM. Means with different
symbols are signiﬁcantly different from one
another. P < 0.05.
Tang et aldemonstrated the role of EGFR signaling in mediating this
process as evidenced by re-expression of vimentin and
Pax2 (two dedifferentiation markers expressed in mesen-
chymal cells, but not in the mature nephron) in injured renal
tubular cells of WT mice and reduced expression in Wa-2
mice after AKI. Similarly, we found that PCNA, a marker
of cell proliferation, was markedly elevated in the kidneys
of WT mice after I/R injury and decreased in Wa-2 mice.
Because proliferation of renal epithelial cells is considered
a cellular response secondary to dedifferentiation and the
predominant mechanism of renal repair, our data suggest168that EGFR activation contributes to renal regeneration after
severe injury.
It has been documented that the reparative response is
usually incomplete in the kidney subjected to severe injury
and is mostly accompanied by ﬁbrogenesis.40 In this study,
we observed that renal expression of collagen I and ﬁbro-
nectin, as well as a-SMA, was up-regulated over time, with
the maximum at 28 days after I/R injury in WT mice;
however, their expression levels were largely suppressed in
the kidney of Wa-2 mice. In addition, we also demonstrated
that EGFR is responsible for proliferation of renal interstitialFigure 8 Expression of p-histone H3 in WT and
Wa-2 mice after chronic I/R injury. A: Photomi-
crographs (200) illustrate p-histone H3 (Serine
10) staining of the kidney tissues collected at day
28 after sham and I/R injury in WT and Wa-2 mice.
B: Epithelial cells with positive staining for p-
histone H3 were counted in 10 high-power ﬁelds
and expressed as means  SEM. C: Lysates of
kidney tissues collected at day 28 after sham and
I/R injury were subjected to immunoblot analysis
with speciﬁc antibodies against p-histone H3 and
a-tubulin. D: The expression levels of p-histone H3
were quantiﬁed by densitometry and normalized
with a-tubulin. Data are means  SEM (n Z 6).
Representative immunoblots are from two samples
from six animals in each group. Means with
different symbols are signiﬁcantly different from
one another. P < 0.05.
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Figure 9 Expression and location of STAT3 after chronic I/R injury in
WT and Wa-2 mice. A: The kidney tissue lysates were subjected to
immunoblot analysis with speciﬁc antibodies against p-STAT3, STAT3, and
a-tubulin. B: The expression levels of p-STAT3 and STAT3 were quantiﬁed
by densitometry, and the ratio between p-STAT3/STAT3 was calculated. C:
Total STAT3 level was normalized with a-tubulin. Data are means  SEM
(n Z 6). Representative immunoblots are from two samples from six
animals in each group. D: The kidney tissues collected at day 28 were used
for co-staining with antibodies to p-STAT3, a-SMA, and DAPI. E: Positive
staining (400) cells of both p-STAT3 and a-SMA, or a-SMA, or p-STAT3
alone were counted in 10 high-power ﬁelds and expressed as means 
SEM. Means with different symbols are signiﬁcantly different from one
another. P < 0.05.
EGFR Mediates Renal Repair and Fibrosismyoﬁbroblasts in kidneys after long-term I/R injury. This
suggests that EGFR mediates renal ﬁbrogenesis under this
pathological condition. Consistent with our observation,
other studies also showed that EGFR activation is involved
in the development/progression of renal ﬁbrosis in different
animal models after chronic injury. It has been reported thatThe American Journal of Pathology - ajp.amjpathol.orgincreased EGFR activation was associated with interstitial
ﬁbrosis and tubular atrophy after prolonged ischemia or
chronic infusion of Ang II10,11; activation of EGFR
promotes transforming growth factor b (TGF b)-dependent
renal ﬁbrosis43; and pharmacological or genetic inhibition of
EGFR inhibits renal deterioration and ﬁbrogenesis induced
by Ang II, UUO, or 5/6 renal nephrectomy.10,11,13 Thus, it
seems that EGFR functions as a double-edged sword,
regulating repair and ﬁbrosis.
The dual role of EGFR in renal regeneration and renal
ﬁbrosis may be associated with the degree and length of
its activation. In contrast to slight and transient EGFR
phosphorylation induced by acute and mild injury,7
chronic and severe kidney injury usually induces pro-
longed activation.13,43 In agreement with this observation,
we demonstrated that severe ischemic injury (renal artery
clamping for 45 minutes) induced a sustained increase in
p-EGFR, which occurred 2 days reperfusion of post-
ischemic injury, gradually increased further and remained
elevated 28 days after ischemic injury. At this point,
increased deposition of extracellular matrix and over-
expression of collagen I, ﬁbronectin, and a-SMA were
clearly detected in the injured kidney. Similar to this
observation, we recently observed that UUO injury induces
a persistent activation of EGFR, which is required for renal
ﬁbrosis.13 Although p-EGFR is mainly expressed in renal
tubular cells soon (2 days) after I/R injury, it is expressed
in both renal tubular and renal interstitial myoﬁbroblasts
later after I/R injury (28 days). Furthermore, we observed
an increased number of renal interstitial cells coexpressing
PCNA and a-SMA in the kidney, which further empha-
sizes the importance of EGFR in regulating activation/
proliferation of renal myoﬁbroblasts. The mechanism that
regulates sustained EGFR activation in the ﬁbrotic kidney
is not completely understood, but persistent production of
EGFR ligands or down-regulation of the machinery
responsible for EGFR activation/degradation may be
involved in this process. In this regard, it was recently
reported that reactive oxygen speciesedependent phos-
phorylation of Src is associated with prolonged activation
of EGFR in cultured renal epithelial cells exposed to
TGF-b1.43 Src may exert this effect through phosphor-
ylation of c-Cbl and/or Cool, two signaling molecules
that participate in the regulation of EGFR endocytosis
and degradation.44,45 Further studies are needed to
address which EGFR ligands are persistently produced
during the course of chronic kidney damage after
ischemic injury.
It has been reported that renal tubular cells arrested in the
G2/M stage of the cell cycle after severe or sustained kidney
injury acquire the ability to produce proﬁbrogenic cytokines
such as TGF-b1 and connective tissue growth factor
(CTGF).37 This suggests that inhibition of epithelial cells
arrested at G2/M phase may help prevent ﬁbrogenesis and
attenuate progression of an acute injury to a chronic one. In
this study, we observed that p-histone-H3, a hallmark of169
Figure 10 Expression and location of Akt after chronic I/R injury in WT
and Wa-2 mice. A: The kidney tissue lysates were subjected to immunoblot
analysis with speciﬁc antibodies against p-Akt, Akt, and a-tubulin. B: The
expression levels of p-Akt and Akt were quantiﬁed by densitometry, and the
ratio between p-Akt and Akt was calculated. C: Total Akt level was
normalized with a-tubulin. Data are means  SEM (nZ 6). Representative
immunoblots are from two samples from six animals in each group. D: The
kidney tissues collected at day 28 were used for co-staining with antibodies
to p-Akt, a-SMA, and DAPI. E: Positive staining (400) cells of both p-Akt
and a-SMA, or a-SMA, or p-Akt alone were counted in 10 high-power ﬁelds
and expressed as means  SEM. Means with different symbols are signiﬁ-
cantly different from one another. P < 0.05.
Tang et alcells arrested at the G2/M stage, was highly expressed in
renal tubular cells of WT mice after I/R injury and largely
inhibited in Wa-2 mice, suggesting that sustained EGFR
activation is capable of promoting renal ﬁbrogenesis
through conversion of renal epithelial cells to a proﬁbrotic
phenotype.170It is interesting to note that PCNA is expressed in the
nuclei of renal tubular cells, but in the cytoplasm of renal
myoﬁbroblasts. It has been documented that PCNA is
a crucial factor in DNA synthesis and repair. Its biological
function in the cytoplasm of renal myoﬁbroblasts is not
clear. Two recent studies showed that PCNA localized in
the cytoplasm of neutrophils is able to interact with
procaspases, preventing their activation and thereby
promoting cell survival.35,36 In this context, the locali-
zation of PCNA in renal myoﬁbroblasts may also enhance
their ability to survive and render them more resistant to
antiﬁbrotic treatments. The cellular mechanism that
controls localization of PCNA to the nucleus or cytoplasm
of different cell types is unclear; our data indicated that
genetic inactivation of EGFR markedly reduced expres-
sion levels of PCNA in both renal tubular cells and
myoﬁbroblasts. This suggests that EGFR activation is
required for biological function of PCNA. Further studies
are needed to address the functional role of cytoplasmic
PCNA in renal interstitial myoﬁbroblasts.
Phosphorylation of EGFR leads to activation of several
important signaling pathways, including STAT3 and Akt. It
has been shown in many cell types that STAT3 and Akt
activation is associated with cell survival and pro-
liferation.28e30,46e48 We demonstrated that phosphorylation
(activation) of STAT3 and Akt is increased in both the early
and late phases following I/R injury in the kidneys of WT
mice, and their phosphorylation was markedly attenuated in
the kidneys of Wa-2 mice, suggesting an important role for
EGFR in modulating their activation in both phases.
Previous studies have shown that active Akt and STAT3 are
primarily located in renal tubular cells,30,49 highlighting the
important role of these signaling pathways in transducing
EGFR activation in renal tubular repair and regeneration. In
the later phase of post I/R injury, p-STAT3 and p-Akt were
predominately located in renal myoﬁbroblasts. These data,
together with our recent observation that p-EGFR is
expressed in myoﬁbroblasts of ﬁbrotic kidney after UUO
injury,13 suggest that activation of these two pathways is
key to EGFR-mediated regulation of renal myoﬁbroblast
activation and proliferation. Because EGFR activation
contributes to PCNA expression, and PCNA is mostly
located in the cytoplasm of renal interstitial myoﬁbroblasts,
it may also modulate renal myoﬁbroblast survival. As
described above, cytoplasmic PCNA has been identiﬁed as
a key regulator of cell lifespan.
The development of ﬁbrosis after acute tubular injury has
important clinical consequence. In recent years, progression
of acute injury to chronic disease due to abnormal repair
mechanisms has gained a great deal of attention. The dual
roles of EGFR in renal repair and ﬁbrosis in severe AKI
suggest that EGFR may be an important therapeutic target.
Although the potential beneﬁcial effect of EGFR activation
in renal structural and functional recovery after acute injury
has been reported in animal studies, our previous and
current studies clearly indicate that prolonged activation ofajp.amjpathol.org - The American Journal of Pathology
EGFR Mediates Renal Repair and FibrosisEGFR is implicated in renal ﬁbrogenesis. This suggests
a limit to using growth factors to enhance renal regeneration
after severe AKI and may also explain why a clinical trial
using insulin-like growth factor-1 (IGF-1) in patients with
AKI failed to promote renal function.50 As with EGFR
activation, induction of IGF-1 receptor activation with IGF-
1 also exerts a proﬁbrotic effect in addition to promoting
growth in renal tubular cells.51Conclusion
In summary, our studies demonstrated that severe I/R injury
induces EGFR activation, which is essential for initiating
the kidney’s regenerative responses through tubular cell
dedifferentiation and proliferation. Sustained EGFR activa-
tion leads to renal ﬁbrogenesis by inducing renal myoﬁ-
broblast activation and proliferation in late phase following
ischemic injury. The different effects of EGFR may be
associated with the degree and length of EGFR activa-
tion and expression in different cell types. Understanding
the molecular mechanism triggering prolonged EGFR acti-
vation following severe kidney injury may help to develop
strategies for accelerating renal regeneration and preventing
renal ﬁbrogenesis.Supplemental Data
Supplemental material for this article can be found at
http://dx.doi.org/10.1016/j.ajpath.2013.04.005.References
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